Decane‐1,2‐diol derivatives as potential antitumor agents for the treatment of glioblastoma
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Pharmacology"
DOI: 10.1016/j.ejphar.2018.08.041
Abstract: ABSTRACT Glioblastoma remains the most common and aggressive type of malignant brain tumor among adults thus, considerable attention has been given to discovery of novel anti‐tumor drugs for its treatment. This study reports the synthesis… read more here.
Keywords: decane; glioblastoma; treatment; decane diol ... See more keywords